# FOSAPREPITANT DIMEGLUMINE
> **ANDA211860** · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2019-09-05
## Drug
- **FDA Application Number:** ANDA211860
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FOSAPREPITANT DIMEGLUMINE
- **Generic name:** FOSAPREPITANT DIMEGLUMINE
- **Active ingredients:** FOSAPREPITANT DIMEGLUMINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2019-09-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211860)
---
*AI Analytics · CC0 1.0*